These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 28595786)

  • 21. An evaluation of the effects of thimerosal on neurodevelopmental disorders reported following DTP and Hib vaccines in comparison to DTPH vaccine in the United States.
    Geier DA; Geier MR
    J Toxicol Environ Health A; 2006 Aug; 69(15):1481-95. PubMed ID: 16766480
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A two-phased population epidemiological study of the safety of thimerosal-containing vaccines: a follow-up analysis.
    Geier DA; Geier MR
    Med Sci Monit; 2005 Apr; 11(4):CR160-70. PubMed ID: 15795695
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparative evaluation of the effects of MMR immunization and mercury doses from thimerosal-containing childhood vaccines on the population prevalence of autism.
    Geier DA; Geier MR
    Med Sci Monit; 2004 Mar; 10(3):PI33-9. PubMed ID: 14976450
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Perinatal hepatitis B transmission and vaccination timing in a managed care cohort: assessment of the temporary delay in newborn hepatitis B vaccination due to thimerosal content.
    Chang S; Begier EM; Schech SD; Venus P; Shatin D; Braun MM; Ball R
    Pediatr Infect Dis J; 2007 Apr; 26(4):329-33. PubMed ID: 17414397
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Addressing the controversy regarding the association between thimerosal-containing vaccines and autism].
    García-Fernández L; Hernández AV; Suárez Moreno V; Fiestas F
    Rev Peru Med Exp Salud Publica; 2013 Apr; 30(2):268-74. PubMed ID: 23949514
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thimerosal-containing vaccines and autistic spectrum disorder: a critical review of published original data.
    Parker SK; Schwartz B; Todd J; Pickering LK
    Pediatrics; 2004 Sep; 114(3):793-804. PubMed ID: 15342856
    [TBL] [Abstract][Full Text] [Related]  

  • 27. When science is not enough - a risk/benefit profile of thiomersal-containing vaccines.
    Clements CJ; McIntyre PB
    Expert Opin Drug Saf; 2006 Jan; 5(1):17-29. PubMed ID: 16370953
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thimerosal exposure in infants and developmental disorders: a prospective cohort study in the United kingdom does not support a causal association.
    Heron J; Golding J;
    Pediatrics; 2004 Sep; 114(3):577-83. PubMed ID: 15342824
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A meta-analysis epidemiological assessment of neurodevelopmental disorders following vaccines administered from 1994 through 2000 in the United States.
    Geier DA; Geier MR
    Neuro Endocrinol Lett; 2006 Aug; 27(4):401-13. PubMed ID: 16807526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurodevelopmental disorders following thimerosal-containing childhood immunizations: a follow-up analysis.
    Geier D; Geier MR
    Int J Toxicol; 2004; 23(6):369-76. PubMed ID: 15764492
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An assessment of thimerosal use in childhood vaccines.
    Ball LK; Ball R; Pratt RD
    Pediatrics; 2001 May; 107(5):1147-54. PubMed ID: 11331700
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thimerosal: clinical, epidemiologic and biochemical studies.
    Geier DA; King PG; Hooker BS; Dórea JG; Kern JK; Sykes LK; Geier MR
    Clin Chim Acta; 2015 Apr; 444():212-20. PubMed ID: 25708367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaccines are not associated with autism: an evidence-based meta-analysis of case-control and cohort studies.
    Taylor LE; Swerdfeger AL; Eslick GD
    Vaccine; 2014 Jun; 32(29):3623-9. PubMed ID: 24814559
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Two-Phase Case-Control Study of Autism Risk Among Children Born From the Late 1990s Through the Early 2000s in the United States.
    Geier DA; Kern JK; Geier MR
    Med Sci Monit; 2016 Dec; 22():5196-5202. PubMed ID: 28031551
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thimerosal exposure & increasing trends of premature puberty in the vaccine safety datalink.
    Geier DA; Young HA; Geier MR
    Indian J Med Res; 2010 Apr; 131():500-7. PubMed ID: 20424300
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Continuing increases in autism reported to California's developmental services system: mercury in retrograde.
    Schechter R; Grether JK
    Arch Gen Psychiatry; 2008 Jan; 65(1):19-24. PubMed ID: 18180424
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methodological issues and evidence of malfeasance in research purporting to show thimerosal in vaccines is safe.
    Hooker B; Kern J; Geier D; Haley B; Sykes L; King P; Geier M
    Biomed Res Int; 2014; 2014():247218. PubMed ID: 24995277
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thimerosal-Preserved Hepatitis B Vaccine and Hyperkinetic Syndrome of Childhood.
    Geier DA; Kern JK; Hooker BS; Sykes LK; Geier MR
    Brain Sci; 2016 Mar; 6(1):. PubMed ID: 26999226
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does thimerosal or other mercury exposure increase the risk for autism? A review of current literature.
    Schultz ST
    Acta Neurobiol Exp (Wars); 2010; 70(2):187-95. PubMed ID: 20628442
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mercury-associated diagnoses among children diagnosed with pervasive development disorders.
    Geier DA; Kern JK; Sykes LK; Geier MR
    Metab Brain Dis; 2018 Jun; 33(3):949-960. PubMed ID: 29512044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.